# A Phase II Trial of Perioperative Chemotherapy With Oxaliplatin, 5-Fluorouracil, Leucovorin(MODIFIED FOLFOX6) in Patients With Locally Advanced Operable Gastric Cancer

> **NCT01851941** · PHASE2 · COMPLETED · sponsor: **Seoul National University Hospital** · enrollment: 52 (actual)

## Conditions studied

- Advanced Gastric Cancer

## Interventions

- **DRUG:** mFOLFOX6 (folinic acid, 5-fluorouracil, and oxaliplatin )

## Key facts

- **NCT ID:** NCT01851941
- **Lead sponsor:** Seoul National University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-10
- **Primary completion:** 2008-06
- **Final completion:** —
- **Target enrollment:** 52 (ACTUAL)
- **Last updated:** 2013-05-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01851941

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01851941, "A Phase II Trial of Perioperative Chemotherapy With Oxaliplatin, 5-Fluorouracil, Leucovorin(MODIFIED FOLFOX6) in Patients With Locally Advanced Operable Gastric Cancer". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01851941. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*